ISRG Stock Recent News
ISRG LATEST HEADLINES
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
One of famed investor Warren Buffett's principles is to buy shares of wonderful companies at fair prices to hold for the long term. Let's try to use it to decide whether Intuitive Surgical (ISRG 1.22%), a medical device specialist, is worth investing in today.
Investors searching for long-duration compounders don't need to overcomplicate things. One approach is to look for market-leading, platform-like business models with recurring economics and management teams investing for the next era of growth.
Intuitive Surgical, Inc. (ISRG) closed at $476.16 in the latest trading session, marking a +1.34% move from the prior day.
Investors have been looking at robotics companies for several decades. But artificial intelligence (AI) is taking robotics beyond basic automation by bringing more precision, flexibility, and adaptability into the sector.
The use of robotics in surgery is on the rise. The market was valued at $800 million in 2015, and has since risen to over $3 billion.
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Intuitive Surgical expands Ion into Australia and Korea after 52% procedure growth, testing Asia-Pacific adoption despite budget headwinds.
Investing styles tend to evolve as people age. Seniors who are already retired often look for steady, reliable, dividend-paying companies.
Intuitive Surgical's Ion platform saw Q2 procedures jump 52% to 35,000, expanding globally as utilization rises despite softer system placements.